MedPath

Effect of Glycyrrhiza glabra on pain and defecation of patients with irritable bowel syndrome

Phase 1
Conditions
Irritable Bowel Syndrome.
????? ???? ????? ????
Registration Number
IRCT138808202696N1
Lead Sponsor
Medical Pelants Research Center (Vice Chancellery for research of Shahrekord Univ. of Med. Sci.)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
90
Inclusion Criteria

Inclusion: patient with reccognized IBS with Rome III criteria,
Exclusion: any bleeding, weight loss, malabsorbtion, anemia, ocult blood, high erythrocyte sedimentation rate,

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain severity. Timepoint: daily for 8 weeks. Method of measurement: QUESTIONNAIRE.;Stool hardness. Timepoint: daily for 8 weeks. Method of measurement: questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath